Strategic partnerships Stevanato Group is actively expanding collaborations, evidenced by a notable partnership with Syntegon Technology to develop the EZ-fill cartridge manufacturing process and ongoing engagements with institutional investors at major healthcare conferences, highlighting opportunities for co-development and larger-scale supply agreements.

On-body delivery The joint efforts in developing a pre-verified on-body delivery platform for 10 mL and 20 mL cartridges position Stevanato as a key enabler for injectable therapies, suggesting upsell opportunities in advanced delivery systems, compatibility testing, and integration services for pharma clients pursuing ready-to-use solutions.

Integrated containment Stevanato offers end-to-end containment and delivery solutions—from glass containers to plastic components and contract manufacturing—creating a compelling value proposition for customers seeking single-source supply chains, reduced time to market, and cost optimization across packaging, filling, and assembly.

Financial momentum Recent earnings strength and revenue growth, along with strategic asset divestitures and capital investments, indicate a robust balance sheet and investment capacity to support client expansions, new line launches, and technology upgrades in containment, sensing, and diagnostic components.

Digital and analytics leverage Adoption of enterprise tools (SAP FICO, Kubernetes, Google Workspace, 365) and analytics/test services for container–drug interactions signals a tech-forward approach; sales opportunities exist in offering data-driven quality assurance, supply chain visibility, and integration services to optimize regulatory-ready product launches.